Epidemiology of candidemia in a tertiary care centre of North India: 5-year study

被引:80
作者
Xess, I. [1 ]
Jain, N. [1 ]
Hasan, F. [1 ]
Mandal, P. [1 ]
Banerjee, U. [1 ]
机构
[1] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India
关键词
D O I
10.1007/s15010-007-6144-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: To determine the distribution of species of Candida and the risk factors associated with candidemia Indian population for which we conducted a retrospective study for 5 years in a tertiary care centre of North India. Materials and Methods: Blood samples from 7,297 aged from 3 days to 85 years, suspected with candidemia, were collected and tested for Candida. The susceptibility patterns toward fluconazole for the year 2005 isolates were tested by micro-dilution assay as described in the CLSI (M27A-2 method). Results: Most of the episodes have been caused by species other than C. albicans. Non-albicans candidemia was 79%-80% in both female and male populations. The most frequent species isolated from 275 patients in 5 years (January 2001-December 2005) was C. tropicalis (35.3%), followed by C. albicans (21.5%), C. parapsilosis (20%), C. glabrata (17.5%), C. krusei (3.3%), C. haemulonii (1.5%), and C. guilliermondii (1%). C. parapsilosis was the predominant in the fifth year of the study (2004-2005). Dose-dependant susceptibility to fluconazole was observed in 5% (n = 3) of the strains. Antifungal resistance was found in 11.7% (n = 7), which includes only C. glabrata. Conclusion: These results were comparable to those derived from other regions of India. C. tropicalis has been reported as the predominant species involved in the cases of candidemia. But in 2005 it has moved toward C. parapsilosis. No true antifungal resistance is reported. Further epidemiological surveillance is needed.
引用
收藏
页码:256 / 259
页数:4
相关论文
共 30 条
[1]   The epidemiology of hematogenous candidiasis caused by different Candida species [J].
AbiSaid, D ;
Anaissie, E ;
Uzun, O ;
Raad, I ;
Pinzcowski, H ;
Vartivarian, S .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1122-1128
[2]  
Agarwal Jyotsna, 2004, Indian Pediatr, V41, P712
[3]  
Al-Jasser AM, 2004, SAUDI MED J, V25, P566
[4]   Candidemia in a tertiary care hospital:: Epidemiology and factors influencing mortality [J].
Alonso-Valle, H ;
Acha, O ;
García-Palomo, JD ;
Fariñas-Alvarez, C ;
Fernánez-Mazarrasa, C ;
Fariñas, MC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (04) :254-257
[5]   Indications for antifungal treatment in intensive care unit patients [J].
Alvarez-Lerma, F ;
Palomar, M ;
León, C ;
Olaechea, P ;
Cerdá, E ;
Bermejo, B .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (05) :279-285
[6]  
Antunes Ana Graciela Ventura, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P239, DOI 10.1590/S0036-46652004000500001
[7]  
Aquino Valério Rodrigues, 2005, Braz J Infect Dis, V9, P411, DOI 10.1590/S1413-86702005000500009
[8]   Epidemiological trends in nosocomial candidemia in intensive care [J].
Bassetti, M ;
Righi, E ;
Costa, A ;
Fasce, R ;
Molinari, MP ;
Rosso, R ;
Pallavicini, FB ;
Viscoli, C .
BMC INFECTIOUS DISEASES, 2006, 6 (1)
[9]   Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital [J].
Bedini, A ;
Venturelli, C ;
Mussini, C ;
Guaraldi, G ;
Codeluppi, M ;
Borghi, V ;
Rumpianesi, F ;
Barchiesi, F ;
Esposito, R .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (01) :75-80
[10]  
Chakrabarti A, 2002, INDIAN J MED RES, V116, P5